Literature DB >> 30115614

Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communities.

Sara C Auld1,2, N Sarita Shah2,3, Barun Mathema4, Tyler S Brown4,5, Nazir Ismail6,7, Shaheed Vally Omar6, James C M Brust8, Kristin N Nelson2, Salim Allana2, Angela Campbell2, Koleka Mlisana9,10, Pravi Moodley10, Neel R Gandhi1,2.   

Abstract

Despite evidence that transmission is driving an extensively drug-resistant TB (XDR-TB) epidemic, our understanding of where and between whom transmission occurs is limited. We sought to determine whether there was genomic evidence of transmission between individuals without an epidemiologic connection.We conducted a prospective study of XDR-TB patients in KwaZulu-Natal, South Africa, during the 2011-2014 period. We collected sociodemographic and clinical data, and identified epidemiologic links based on person-to-person or hospital-based connections. We performed whole-genome sequencing (WGS) on the Mycobacterium tuberculosis isolates and determined pairwise single nucleotide polymorphism (SNP) differences.Among 404 participants, 123 (30%) had person-to-person or hospital-based links, leaving 281 (70%) epidemiologically unlinked. The median SNP difference between participants with person-to-person and hospital-based links was 10 (interquartile range (IQR) 8-24) and 16 (IQR 10-23), respectively. The median SNP difference between unlinked participants and their closest genomic link was 5 (IQR 3-9) and half of unlinked participants were within 7 SNPs of at least five participants.The majority of epidemiologically-unlinked XDR-TB patients had low pairwise SNP differences with at least one other participant, consistent with transmission. These data suggest that much of transmission may result from casual contact in community settings between individuals not known to one another.
Copyright ©ERS 2018.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30115614      PMCID: PMC6195447          DOI: 10.1183/13993003.00246-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  32 in total

Review 1.  Molecular epidemiology of tuberculosis: current insights.

Authors:  Barun Mathema; Natalia E Kurepina; Pablo J Bifani; Barry N Kreiswirth
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

2.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.

Authors:  J D van Embden; M D Cave; J T Crawford; J W Dale; K D Eisenach; B Gicquel; P Hermans; C Martin; R McAdam; T M Shinnick
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

3.  Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study.

Authors:  Keertan Dheda; Jason D Limberis; Elize Pietersen; Jody Phelan; Aliasgar Esmail; Maia Lesosky; Kevin P Fennelly; Julian Te Riele; Barbara Mastrapa; Elizabeth M Streicher; Tania Dolby; Abdallah M Abdallah; Fathia Ben-Rached; John Simpson; Liezel Smith; Tawanda Gumbo; Paul van Helden; Frederick A Sirgel; Ruth McNerney; Grant Theron; Arnab Pain; Taane G Clark; Robin M Warren
Journal:  Lancet Respir Med       Date:  2017-01-19       Impact factor: 30.700

4.  Proportion of tuberculosis transmission that takes place in households in a high-incidence area.

Authors:  Suzanne Verver; Robin M Warren; Zahn Munch; Madalene Richardson; Gian D van der Spuy; Martien W Borgdorff; Marcel A Behr; Nulda Beyers; Paul D van Helden
Journal:  Lancet       Date:  2004-01-17       Impact factor: 79.321

5.  Transmission of tuberculosis in a South African community with a high prevalence of HIV infection.

Authors:  Keren Middelkoop; Barun Mathema; Landon Myer; Elena Shashkina; Andrew Whitelaw; Gilla Kaplan; Barry Kreiswirth; Robin Wood; Linda-Gail Bekker
Journal:  J Infect Dis       Date:  2014-07-22       Impact factor: 5.226

6.  Role of casual contacts in the recent transmission of tuberculosis in settings with high disease burden.

Authors:  W Wang; B Mathema; Y Hu; Q Zhao; W Jiang; B Xu
Journal:  Clin Microbiol Infect       Date:  2014-07-29       Impact factor: 8.067

7.  Tuberculosis transmission attributable to close contacts and HIV status, Malawi.

Authors:  Amelia C Crampin; Judith R Glynn; Hamidou Traore; Malcolm D Yates; Lorren Mwaungulu; Michael Mwenebabu; Steven D Chaguluka; Sian Floyd; Francis Drobniewski; Paul E M Fine
Journal:  Emerg Infect Dis       Date:  2006-05       Impact factor: 6.883

8.  Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study.

Authors:  Timothy M Walker; Camilla L C Ip; Ruth H Harrell; Jason T Evans; Georgia Kapatai; Martin J Dedicoat; David W Eyre; Daniel J Wilson; Peter M Hawkey; Derrick W Crook; Julian Parkhill; David Harris; A Sarah Walker; Rory Bowden; Philip Monk; E Grace Smith; Tim E A Peto
Journal:  Lancet Infect Dis       Date:  2012-11-15       Impact factor: 25.071

Review 9.  Interpreting whole genome sequencing for investigating tuberculosis transmission: a systematic review.

Authors:  Hollie-Ann Hatherell; Caroline Colijn; Helen R Stagg; Charlotte Jackson; Joanne R Winter; Ibrahim Abubakar
Journal:  BMC Med       Date:  2016-03-23       Impact factor: 8.775

10.  Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis.

Authors:  Emily A Kendall; Mariam O Fofana; David W Dowdy
Journal:  Lancet Respir Med       Date:  2015-11-18       Impact factor: 30.700

View more
  11 in total

1.  The role of prisons in disseminating tuberculosis in Brazil: A genomic epidemiology study.

Authors:  Katharine S Walter; Paulo César Pereira Dos Santos; Thais Oliveira Gonçalves; Bruna Oliveira da Silva; Andrea da Silva Santos; Alessandra de Cássia Leite; Alessandra Moura da Silva; Flora Martinez Figueira Moreira; Roberto Dias de Oliveira; Everton Ferreira Lemos; Eunice Cunha; Yiran E Liu; Albert I Ko; Caroline Colijn; Ted Cohen; Barun Mathema; Julio Croda; Jason R Andrews
Journal:  Lancet Reg Health Am       Date:  2022-02-01

2.  Clusters of Drug-Resistant Mycobacterium tuberculosis Detected by Whole-Genome Sequence Analysis of Nationwide Sample, Thailand, 2014-2017.

Authors:  Ditthawat Nonghanphithak; Angkana Chaiprasert; Saijai Smithtikarn; Phalin Kamolwat; Petchawan Pungrassami; Virasakdi Chongsuvivatwong; Surakameth Mahasirimongkol; Wipa Reechaipichitkul; Chaniya Leepiyasakulchai; Jody E Phelan; David Blair; Taane G Clark; Kiatichai Faksri
Journal:  Emerg Infect Dis       Date:  2021-03       Impact factor: 16.126

3.  Whole genome sequencing identifies bacterial factors affecting transmission of multidrug-resistant tuberculosis in a high-prevalence setting.

Authors:  Avika Dixit; Luca Freschi; Roger Vargas; Roger Calderon; James Sacchettini; Francis Drobniewski; Jerome T Galea; Carmen Contreras; Rosa Yataco; Zibiao Zhang; Leonid Lecca; Sergios-Orestis Kolokotronis; Barun Mathema; Maha R Farhat
Journal:  Sci Rep       Date:  2019-04-03       Impact factor: 4.379

4.  New Quinolone-Based Thiosemicarbazones Showing Activity Against Plasmodium falciparum and Mycobacterium tuberculosis.

Authors:  Richard M Beteck; Ronnett Seldon; Audrey Jordaan; Digby F Warner; Heinrich C Hoppe; Dustin Laming; Setshaba D Khanye
Journal:  Molecules       Date:  2019-05-04       Impact factor: 4.411

Review 5.  Deciphering drug resistance in Mycobacterium tuberculosis using whole-genome sequencing: progress, promise, and challenges.

Authors:  Keira A Cohen; Abigail L Manson; Christopher A Desjardins; Thomas Abeel; Ashlee M Earl
Journal:  Genome Med       Date:  2019-07-25       Impact factor: 11.117

6.  Genetic diversity of Mycobacterium tuberculosis strains circulating in Botswana.

Authors:  Tuelo Mogashoa; Pinkie Melamu; Serej D Ley; Elizabeth M Streicher; Thato Iketleng; Nametso Kelentse; Lucy Mupfumi; Margaret Mokomane; Botshelo Kgwaadira; Vladimir Novitsky; Ishmael Kasvosve; Sikhulile Moyo; Robin M Warren; Simani Gaseitsiwe
Journal:  PLoS One       Date:  2019-05-07       Impact factor: 3.240

7.  Reporting practices for genomic epidemiology of tuberculosis: a systematic review of the literature using STROME-ID guidelines as a benchmark.

Authors:  Brianna Cheng; Marcel A Behr; Benjamin P Howden; Theodore Cohen; Robyn S Lee
Journal:  Lancet Microbe       Date:  2021-03-02

Review 8.  Application of Next Generation Sequencing for Diagnosis and Clinical Management of Drug-Resistant Tuberculosis: Updates on Recent Developments in the Field.

Authors:  Navisha Dookie; Azraa Khan; Nesri Padayatchi; Kogieleum Naidoo
Journal:  Front Microbiol       Date:  2022-03-24       Impact factor: 5.640

9.  High clustering rate and genotypic drug-susceptibility screening for the newly recommended anti-tuberculosis drugs among global extensively drug-resistant Mycobacterium tuberculosis isolates.

Authors:  Kanwara Trisakul; Ditthawat Nonghanphithak; Pratchakan Chaiyachat; Orawee Kaewprasert; Kankanon Sakmongkoljit; Wipa Reechaipichitkul; Angkana Chaiprasert; David Blair; Taane G Clark; Kiatichai Faksri
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

10.  Population-based sequencing of Mycobacterium tuberculosis reveals how current population dynamics are shaped by past epidemics.

Authors:  Irving Cancino-Muñoz; Mariana G López; Manuela Torres-Puente; Luis M Villamayor; Rafael Borrás; María Borrás-Máñez; Montserrat Bosque; Juan J Camarena; Caroline Colijn; Ester Colomer-Roig; Javier Colomina; Isabel Escribano; Oscar Esparcia-Rodríguez; Francisco García-García; Ana Gil-Brusola; Concepción Gimeno; Adelina Gimeno-Gascón; Bárbara Gomila-Sard; Damiana Gónzales-Granda; Nieves Gonzalo-Jiménez; María Remedios Guna-Serrano; José Luis López-Hontangas; Coral Martín-González; Rosario Moreno-Muñoz; David Navarro; María Navarro; Nieves Orta; Elvira Pérez; Josep Prat; Juan Carlos Rodríguez; Ma Montserrat Ruiz-García; Hermelinda Vanaclocha; Iñaki Comas
Journal:  Elife       Date:  2022-07-26       Impact factor: 8.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.